TYO:4886 Revenue

In the fiscal year ending March 31, 2025, ASKA Pharmaceutical Holdings had annual revenue of 64.14B JPY with 2.06% growth. ASKA Pharmaceutical Holdings had revenue of 14.21B in the quarter ending March 31, 2025, with 1.38% growth.

Revenue

64.14B

Revenue Growth

+2.06%

P/S Ratio

1.04

Revenue / Employee

39.30M

Employees

1,632

Market Cap

66.85B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	64.14B	1.30B	2.06%
Mar 31, 2024	62.84B	2.38B	3.94%
Mar 31, 2023	60.46B	3.85B	6.81%
Mar 31, 2022	56.61B	1.43B	2.58%
Mar 31, 2021	55.18B	2.64B	5.02%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,222.12B
Takeda Pharmaceutical Company	4,581.55B
HOYA Corporation	866.03B
Daiichi Sankyo Company	1,886.26B
Terumo	1,036.17B
Otsuka Holdings	2,393.18B
Astellas Pharma	1,912.32B
Shionogi &	438.27B

Revenue Rankings